Shane Olwill
2023
In 2023, Shane Olwill earned a total compensation of $705.4K as Former Senior Vice President and Chief Development Officer at Pieris Pharmaceuticals.
Compensation breakdown
| Bonus | $127,702 |
|---|---|
| Option Awards | $241,536 |
| Salary | $328,614 |
| Other | $7,593 |
| Total | $705,445 |
Olwill received $328.6K in salary, accounting for 47% of the total pay in 2023.
Olwill also received $127.7K in bonus, $241.5K in option awards and $7.6K in other compensation.
Rankings
In 2023, Shane Olwill's compensation ranked 1,595th out of 2,918 executives tracked by ExecPay. In other words, Olwill earned more than 45.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,595 out of 2,918 | 45th |
Division Manufacturing | 939 out of 1,608 | 42nd |
Major group Chemicals And Allied Products | 601 out of 901 | 33rd |
Industry group Drugs | 585 out of 864 | 32nd |
Industry Pharmaceutical Preparations | 414 out of 622 | 33rd |
Source: SEC filing on November 6, 2024.
Olwill's colleagues
We found two more compensation records of executives who worked with Shane Olwill at Pieris Pharmaceuticals in 2023.